Location History:
- London, GB (1999)
- Bologna, IT (2011)
Company Filing History:
Years Active: 1999-2011
Title: The Innovative Contributions of Elisabetta Gianasi
Introduction: Elisabetta Gianasi is a prominent inventor based in Bologna, Italy, known for her significant contributions to the field of biochemistry and medicine. With two patents to her name, she has made strides in developing novel compounds that have the potential to transform treatment methodologies in medicine and veterinary medicine.
Latest Patents: Gianasi's latest inventions highlight her dedication to advancing scientific understanding and practical applications. One of her notable patents is for "Glycodendrimers having biological activity." This invention relates to new anionic glycodendrimers that possess unique biological activity, as well as processes for their preparation and application in various medical contexts, including veterinary medicine. Another significant patent is for "Polymer-platinum compounds," which details a polymer-platinum compound intended for tumor treatment. This compound is designed with a polymer backbone featuring platinum-containing side chains, which include an oligopeptide attached to both the backbone and the platinum compound.
Career Highlights: Throughout her career, Elisabetta Gianasi has worked with several innovative companies. Notable organizations include Access Pharmaceuticals, Inc. and Imperial Innovations Limited, where she has utilized her expertise in biochemistry to develop groundbreaking technologies and compounds.
Collaborations: Gianasi has also collaborated with esteemed colleagues in the field, including Ruth Duncan and Evagoras G Evagorou. These partnerships have played a critical role in propelling her research forward and expanding the impact of her inventions.
Conclusion: Elisabetta Gianasi stands out as an inventor who has significantly impacted the fields of medicine and biology. Through her innovative patents and collaborations, she continues to drive progress in therapeutic applications, showcasing the power of creativity and research in tackling complex medical challenges.